HPHA Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Heidelberg Pharma AG

Watchlist Manager

Watchlist

Price: 2.47 EUR 0.82%

Market Cap: €115.1m

H	Heidelberg Pharma AG DUS:HPHA	DE
C	Carlisle Companies Inc XMUN:CLE	US
W	Wilmar International Ltd F:RTHA	SG
	JD Logistics Inc F:822	CN
M	Motorola Solutions Inc XMUN:MTLA	US
	Daiichi Life Group Inc OTC:DCNSF	JP
D	DigitalOcean Holdings Inc XMUN:0SU	US
F	FirstEnergy Corp F:FE7	US
	Yara International ASA OSE:YAR	NO
A	Avis Budget Group Inc F:CUCA	US
T	Telefonaktiebolaget LM Ericsson XMUN:ERCB	SE
K	Kellanova SWB:KEL	US
V	Versant Media Group Inc NASDAQ:VSNT	US
V	Volkswagen AG PSE:VOW	DE

Profitability Summary

Heidelberg Pharma AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

87%

Strong 3Y Average Gross Margin

79%

Gross Margin is Increasing

73% > 87%

Negative Operating Margin

-432%

Negative 3Y Average Operating Margin

-670%

Declining Operating Margin

-238% > -432%

Negative Net Margin

-445%

Negative 3Y Average Net Margin

-635%

Declining Net Margin

-236% > -445%

Negative Free Cash Flow Margin

-334%

Negative 3Y Average Free Cash Flow Margin

-648%

Free Cash Flow Margin is Increasing

-374% > -334%

Negative ROE

-1.540%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-124%

Declining ROIC

-133% > -162%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.